The experiences of 585 people when they tried to withdraw from antipsychotic drugs

D’Abreu, 2018, Tardive dyskinesia: Epidemiology, Journal of Neurological Science, 389, 17, 10.1016/j.jns.2018.02.007 American Psychiatric Association. (2020). Practice guideline for the treatment of patients with schizophrenia, (3rd ed.). A.P.A. . Brandt, 2020, Antipsychotic withdrawal symptoms: A systematic review and meta-analysis, Frontiers of Psychiatry, 11, 10.3389/fpsyt.2020.569912 Brandt, 2022, Adverse events after antipsychotic discontinuation: An individual participant data meta-analysis, Lancet Psychiatry, 9, 232, 10.1016/S2215-0366(22)00014-1 Bülow, 2016, Experience of psychotropic medication – an interview study of persons with psychosis, Issues in Mental Health Nursing, 37, 820, 10.1080/01612840.2016.1224283 Chouinard, 2017, Antipsychotic-induced dopamine supersensitivity psychosis: Pharmacology, Criteria, and therapy, Psychotherapy and Psychosomatics, 86, 189, 10.1159/000477313 Cooper, 2005, Ambulatory use of olanzapine and risperidone: A population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia, Canadian Journal of Psychiatry, 50, 901, 10.1177/070674370505001404 Cooper, 2020, The case for including antipsychotics in the UK NICE guideline: ‘Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults’. Psychosis: Psychological, Social and Integrative Approaches, 12, 89 Cooper, 2019, Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation, PloS One, 14, 1, 10.1371/journal.pone.0218711 Davies, 2019, A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?, Addictive Behaviours, 97, 111, 10.1016/j.addbeh.2018.08.027 Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). (2019). S3-Leitlinie Schizophrenie. AWMF-Register Nr. 038-009. DGPPN. Framer, 2021, What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications, Therapeutic Advances in Psychopharmacology, 11, 1, 10.1177/2045125321991274 Guy, A., Davies, J., & Rizq, R. (Eds.)(2019). Guidance for psychologicaltherapists: Enabling conversations with clients taking orwithdrawing from prescribed psychiatric drugs. All Party Parliamentary Groupfor Prescribed Drug Dependence. Ho, 2011, Long-term antipsychotic treatment and brain volumes, Archives of General Psychiatry, 2011, 128, 10.1001/archgenpsychiatry.2010.199 Horowitz, 2019, Tapering of SSRI treatment to mitigate withdrawal symptoms, Lancet Psychiatry, 6, 538, 10.1016/S2215-0366(19)30032-X Horowitz, 2021, A method for tapering antipsychotic treatment that may minimize the risk of relapse, Schizophrenia Bulletin, 47, 1116, 10.1093/schbul/sbab017 Horowitz, 2022, Tapering antipsychotic medication: Practical considerations, Psychological Medicine, 52, 32, 10.1017/S0033291721003299 Hutton, 2013, Antipsychotic drugs, 105 Lacro, 2002, Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature, Journal of Clinical Psychiatry, 63, 892, 10.4088/JCP.v63n1007 Larsen-Barr, 2018, Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success, Psychiatry Research, 270, 365, 10.1016/j.psychres.2018.10.001 Larsen-Barr, 2018, Attempting to stop antipsychotic medication: Success, supports and efforts to cope, Social Psychiatry and Psychiatric Epidemiology, 53, 745, 10.1007/s00127-018-1518-x Larsen-Barr, M., & Seymour, F. (2021). Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication. Therapeutic Advances in Psychopharmacology, doi.org/10.1177/2045125321989133. Lepping, 2011, Clinical relevance of findings in trials of antipsychotics: Systematic review, British Journal of Psychiatry, 198, 341, 10.1192/bjp.bp.109.075366 Lewis, 2021, Four research papers I wish my GP had read before prescribing antidepressants, British Journal of General Practice, 71, 316, 10.3399/bjgp21X716321 Lieberman, 2005, Effectiveness of antipsychotic drugs in patients with chronic schizophrenia, New England Journal of Medicine, 353, 1209, 10.1056/NEJMoa051688 Longden, 2016, Assessing and reporting the adverse effects of antipsychotic medication: A systematic review of clinical studies, and prospective, retrospective, and cross-sectional research, Clinical Neuropharmacology, 39, 29, 10.1097/WNF.0000000000000117 Marston, 2014, Prescribing of antipsychotics in UK primary care: A cohort study, BMJ Open, 4, 10.1136/bmjopen-2014-006135 Mind. (2021). Withdrawal from antipsychotics. https://www.mind.org.uk/information-support/drugs-and-treatments/antipsychotics/coming-off-antipsychotics/ Accessed December 4, 2021. Moncrieff, 2006, Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse, Acta Psychiatrica Scandinavica, 114, 3, 10.1111/j.1600-0447.2006.00787.x Moncrieff, J., Gupta, S., & Horowitz, M. (2020). Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder. Therapeutic Advances in Psychopharmacology, 10, 2045125320937910. Moncrieff, 2019, A randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: The RADAR trial (Research into Antipsychotic Discontinuation and Reduction): Protocol paper, BMJ Open, 9, 10.1136/bmjopen-2019-030912 Moncrieff, 2015, Antipsychotic maintenance treatment: Time to rethink?, PLoS Medicine, 12, 1, 10.1371/journal.pmed.1001861 Moncrieff, 2009, The subjective experience of taking antipsychotic medication: A content analysis of internet data, Acta Psychiatrica Scandinavica, 120, 102, 10.1111/j.1600-0447.2009.01356.x Morrison, 2012, Antipsychotics: Is it time to introduce patient choice ?, British Journal of Psychiatry, 201, 83, 10.1192/bjp.bp.112.112110 Murray, 2016, Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics, British Journal of Psychiatry, 209, 361, 10.1192/bjp.bp.116.182683 NHS Business Services Authority (2021). Medicines used in mental health, England, April 2015 to December 2020: Quarterly summary statistics. https://nhsbsa-opendata.s3.eu-west-2.amazonaws.com/mumh-2021-q3-narrative-v001.html. Nosé, 2003, How often do patients with psychosis fail to adhere to treatment programmes? A systematic review, Psychological Medicine, 33, 1149, 10.1017/S0033291703008328 Read, 2014, Adverse emotional and interpersonal effects reported by 1,829 New Zealanders while taking antidepressants, Psychiatry Research, 216, 67, 10.1016/j.psychres.2014.01.042 Read, 2018, How many of 1,829 antidepressant users report withdrawal symptoms or addiction?, International Journal of Mental Health Nursing, 27, 1805, 10.1111/inm.12488 Read, 2019, What do we know about withdrawal?, 74 Read, 2020, Using open questions to understand 650 people’s experiences with antipsychotic drugs, Schizophrenia Bulletin, 46, 896, 10.1093/schbul/sbaa002 Read, 2018, Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects, Current Drug Safety, 13, 176, 10.2174/1574886313666180605095130 Read, 2019, Positive and negative effects of antipsychotic medication: An international online survey of 832 recipients, Current Drug Safety, 14, 173, 10.2174/1574886314666190301152734 Snyder, 1974 Stea, J. (2020). Drug addiction vs drug dependence. Psychology Today, March 6. https://www.psychologytoday.com/gb/blog/writing-integrity/202003/drug-addiction-vs-drug-dependence. Accessed November 4, 2021. Steingard, 2018, Five year outcomes of tapering antipsychotic drug doses in a community mental health center, Community Mental Health Journal, 54, 1097, 10.1007/s10597-018-0313-1 Taylor, 2019, 2019 Taylor, D., Barnes, T., & Young, A. (2018). The Maudsley prescribingguidelines inpsychiatry (13th ed.). Wiley. Taylor, D., Barnes, T., & Young, A. (2021). The Maudsley prescribingguidelines inpsychiatry (14th ed.). Wiley. Weinmann, 2010, Antipsychotic medication, mortality and neurodegeneration. Psychosis: Psychological, Social & Integrative Approaches, 2, 250 White, 2021, The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: Is social media filling the void left by health services?, Therapeutic Advances in Psychopharmacology, 10.1177/2045125320981174 Yin, 2017, Antipsychotic induced dopamine supersensitivity psychosis: A comprehensive review, Current Neuropharmacology, 15, 174, 10.2174/1570159X14666160606093602